SCHEMBL17155018

SCHEMBL17155018

COC(=O)C1(N2CCC(N(C)c3cccc([N+](=O)[O-])c3F)CC2)CC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.37
LMNA P02545 3/20 0.36
NPC1 O15118 1/20 0.36
HTT P42858 1/20 0.36
RAB9A P51151 1/20 0.36
MAPT P10636 7/20 0.35
OPRL1 P41146 2/20 0.34
OPRM1 P35372 2/20 0.34
ALDH1A1 P00352 5/20 0.33
TDP1 Q9NUW8 2/20 0.33
OPRD1 P41143 1/20 0.33
KDM4E B2RXH2 2/20 0.33
NPSR1 Q6W5P4 1/20 0.32
CCR5 P51681 1/20 0.32
MAPK1 P28482 2/20 0.31
ABCC4 O15439 1/20 0.31
PLIN1 O60240 1/20 0.31
CACNA1F O60840 1/20 0.31
GMNN O75496 1/20 0.31
KCNK2 O95069 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17155368 0.84 OPRL1 (0.36) OPRL1OPRM1OPRD1CCR5KCNH2
SCHEMBL18406815 0.82 SCD (0.39) MAPTOPRL1OPRM1ALDH1A1TDP1
SCHEMBL17155077 0.80 MAPK1 (0.42) KMT2ALMNARAB9AMAPTOPRL1
SCHEMBL17154975 0.78 CCR5 (0.39) KMT2AMAPTALDH1A1NPSR1CCR5
SCHEMBL17154935 0.74 ALDH1A1 (0.39) MAPTALDH1A1KDM4ENPSR1MAPK1
SCHEMBL18411395 0.73 OPRL1 (0.37) KMT2AOPRL1OPRM1OPRD1KDM4E
SCHEMBL18411503 0.72 CCR5 (0.39) OPRL1OPRM1ALDH1A1OPRD1CCR5
SCHEMBL17155364 0.71 CCR5 (0.39) OPRL1OPRM1OPRD1CCR5KCNH2
SCHEMBL17155367 0.67 PKM (0.47) KMT2ANPC1HTTRAB9AMAPT
SCHEMBL230285 0.67 PKM (0.58) KMT2ALMNANPC1ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170022201-A1 MACROCYLIC PYRIDINE DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 2017-01-26 US disclosed
WO-2015150557-A1 MACROCYLIC PYRIDINE DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 2015-10-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170022201-A1 MACROCYLIC PYRIDINE DERIVATIVES VPS26B, VPS4B, VPS28 KMT2A 3748/4885LMNA 4810/4885NPC1 776/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.